Fig. 1

Experimental overview of capsid and delivery route comparisons. (A) WT FVBN/J mice at ~ 6 weeks of age were injected via intracerebroventricular (ICV), intrathecal (IT), or jugular vein (IV) injections with AAV9 or AAV-DJ to deliver a luciferase - yellow fluorescent protein (YFP) fusion protein. (B) Mice were evaluated throughout the study through non-invasive luciferase live imaging at the end of weeks 3 (I), 7 (II) and 9 (III). Nine weeks after AAV delivery, six mice (3 males and 3 females) were euthanized for DNA, RNA, and protein analysis and four mice (2 males and 2 females) for histological studies